
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

September 2, 2022
Last week, we featured our final Summer Weekend Read, the last in a series designed to showcase some of our most recent...
Read article

August 26, 2022
Discover the Value of an Optimized Clinical Data Strategy
To continue our Summer Weekend Reads series, Cytel presents “Discover the Value of an Optimized Clinical Data Strategy”...
Read article

March 5, 2021
Single Arm Multi-Stage Phase 2 Cancer Trials
Early stage Phase 2 clinical trials are often designed as multi-stage single arm trials, which quickly identify...
Read article

November 12, 2018
Can Statisticians Contribute to Enhance the Position of Patients in Clinical Trials?
In this blog, we talk with Robert Greene, Founder and President of the HungerNDThirst Foundation, about his upcoming...
Read article

October 5, 2018
Interview with Stephen Senn: 70 Years and Still Here: The Randomized Clinical Trial and its Critics
We are delighted that Stephen Senn will be joining us at the EUGM on November 14th and 15th in Darmstadt, Germany. In...
Read article

September 27, 2018
Decision Making in Development Programs with Targeted Therapies: with Heiko Götte
In this blog, we talk with Heiko Götte, Senior Expert Biostatistician at Merck about his upcoming presentation at...
Read article

August 15, 2018
2018 East User Group Meeting Addresses Multiplicity Themes, with keynotes including Stephen Senn and Meinhard Keiser.
Cytel’s 7th East User Group Meeting (EUGM) will take place on November 14 & 15, 2018 at Merck in Darmstadt, Germany,...
Read article

July 3, 2018
Unveiling New East 6.5 Modules: Join Our Webinar
It’s shaping up to be a busy year for Cytel’s software development team with a number of upgrades and planned launches...
Read article

October 31, 2017
Webinar Replay: Dual Target Methods for Go/No-Go Decision Making
As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca...
Read article

October 18, 2017
Webinar Replay: Phase 2 Trial Designs using Program-level Simulations
Cytel's new Trial Innovations Webinar Series provides a platform for the most promising new statistical approaches...
Read article

February 9, 2017
Inside an Oncology Statistician's Toolkit
In this blog, Adam Hamm, PhD, Director Biostatistics at Cytel shares some of the most important knowledge he uses in...
Read article

October 11, 2016
Simulations to optimize clinical trial programs
Its important to take a strategic approach to clinical development in order to minimize the potential for Phase 3...
Read article

September 27, 2016
Practical Challenges of the LUNG-MAP study
The Lung-MAP trial is an innovative biomarker driven 'precision medicine' study which evaluates five novel agents for...
Read article
September 9, 2016
Case Study:Seamless Phase 2/3 Design in Rare Disease
Challenge: Our client, an emerging biotechnology company, was preparing for the next stage of development for their...
Read article

July 18, 2016
Adaptive Design in the limelight with NEJM article
In order for adaptive designs to reach their potential, it’s critical that knowledge is effectively dissemirnated...
Read article

April 26, 2016
Overcoming Data Management Challenges in Oncology Studies
In this blog we’ll highlight some unique challenges that are encountered from a Data Management perspective when...
Read article

April 5, 2016
What's the price of pharma innovation?
Cost of pharmaceutical development and R&D productivity is an ongoing industry concern, consistently discussed in the...
Read article

March 29, 2016
Decision Making in Early Clinical Development
On March 16th and 17th the 5th East User Group Meeting took place in London. This very successful 2 days saw a variety...
Read article

July 21, 2015
MCP-Mod for the Modern Dose-Ranging Clinical Trial
MCP-Mod methodology for dose-ranging clinical trials has been gaining popularity since the 2013 publication of the...
Read article

May 20, 2015
Seamless Adaptive Clinical Trials: What’s really at stake?
Seamless adaptive clinical trials have gained popularity for reducing the projected time it takes to complete the...
Read article